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Zone of inhibitionAbstract Introduction: Microbial diseases are increasing year by year and they are becoming a big
threat to public health. There are more than 200 known diseases transmitted by bacteria, fungi,
viruses, prions, rickettsia and other microbes to humans. The emergence of drug resistance to chem-
ical drugs is the biggest threat in controlling human pathogens. Hence novel antimicrobial agents
from actinomycetes are timely needed for the control of several human pathogens.
Aim: The aim was to ﬁnd some actinomycetes with antimicrobial metabolites.
Methods: Soil samples were collected from Nilgiris district in Western Ghats of Tamil Nadu, India.
Actinomycetes were isolated using serial dilution and plating techniques on actinomycetes isolation
agar. Streptomycin and ketoconazole (25 lg/disc) were used as reference controls. The active strains
were identiﬁed by 16S rRNA and phylogenetic tree was constructed; the sequences were submitted
in the GenBank.
Results: Totally 106 actinomycete strains were isolated and cross streaked against various human
microbial pathogens. Only 44 (41.50%) exhibited good antimicrobial activity against different
pathogenic microbes. Five isolates (FMS-20, TGH-30, TGH-31, TGH-31-1 and IS-4) were chosen
for secondary screening using ﬁltrate. Among them FMS-20 ﬁltrate showed good inhibition on the
16th day against all tested microbial pathogens. Further the intracellular methanol extract of FMS-
20 showed maximum zone of inhibition against A. brasiliensis (22 mm) at 5 mg/disc. Similarly the
extracellular ethyl acetate extract of FMS-20 showed maximum zone of inhibition against B. subtilis
(25 mm).l.: +91
, http://
2 P. Ganesan et al.
Please cite this article in press as: Ganesan P e
dx.doi.org/10.1016/j.ajme.2016.03.004Conclusions: The present work revealed that, among 106 actinomycetes screened, Streptomyces
rimosus (FMS-20) (Accession No-KT827106) showed promising antimicrobial activity against all
the tested human microbial pathogens.
 2016 Alexandria University Faculty of Medicine. Production and hosting by Elsevier B.V. This is an
open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).1. Introduction
Microbial diseases are increasing year by year and they are
becoming a big threat to public health.1–4 There are more than
200 known diseases transmitted by bacteria, fungi, viruses, pri-
ons, rickettsia and other microbes to humans.5,6 Among the
different microbial pathogens, viruses or prions cause 37–
44% of diseases, bacteria or rickettsia cause 10–30% of dis-
eases, protozoa cause 10.7% of diseases, fungi cause 6.3% of
diseases and helminths cause 3.3% of diseases, leading to mil-
lions of death every year.7–9 Many bacteria excrete through
faeces, which can cause undesirable effects in health and envi-
ronment.10–13 The emergence of drug and multidrug-resistant
pathogen is the biggest threat; consequently, novel antimicro-
bial agents from natural sources with novel mechanisms of
action, are urgently needed in medical and pharmaceutical
sectors.
Many research works have been carried out to control the
pathogens and to identify new antimicrobial agents.14–16
Microbes from soils are the most important natural sources
exhibiting strong biological activity against a wide range of
pathogens.17 Generally microbes produce bioactive molecules
which are unnecessary for their growth and development but
useful in defence mechanism.18 Soil microorganisms in partic-
ular are intensively exploited.19
Actinomycetes are Gram positive, ﬁlamentous bacteria
with 55% of guanine and cytosine in their DNA.20–23 Actino-
mycetes represent one of the most important classes of bacteria
for their ability to produce a wide range of biologically active
secondary metabolites, which are very effective against micro-
bial pathogens.20,23 More than 70–80% of all known antibi-
otics have been isolated from actinomycetes and are used in
medicine and agriculture.24 The genus Streptomyces is the big-
gest producer of antibiotics. Several microbial secondary
metabolites are reported to be rich sources of therapeutic
drugs.25,26
The present study aimed to evaluate some actinomycetes
from different soils for antimicrobial activity against human
pathogens.
2. Materials and methods
2.1. Isolation of actinomycetes from soil samples
Soil samples were collected from ﬁve different places in Wes-
tern Ghats of Tamil Nadu India viz., Topslip greenhouse
(TGH), Fishery mountain, (FMS), near dam mountain
(NDM), Iduhatty (IS) and Kothagiri (KS). The soil samples
were collected from 15 cm depth using sterile technique as
per the method of Valan Arasu et al.20 and transported to
the laboratory. These soil samples were air-dried for 34 h at
45 C, crushed, and sieved prior to use for isolation followingt al. Antimicrobial activity of some actinestablished method.27 The isolation of actinomycetes was done
by standard serial dilution method. One gram of soil was sus-
pended in 9 ml of sterile double-distilled water. The dilution
was carried out up to 105 dilutions. Aliquots (0.1 ml) of
102, 103, 104, and 105 were spread on the actinomycetes
isolation agar (AIA) medium containing nalidixic acid
(100 mg/l) and ketoconazole (30 mg/l) and incubated at
30 C for 7–10 days.20,28–31 Based on the colony morphological
characterization, the actinomycetes were selected and puriﬁed
on ISP-2 (International Streptomyces project medium No. 2).
2.2. Morphological characterization of isolates
Morphological features of active isolates were observed with a
light microscope.18,20,30,32–34 Morphological features were
observed in various media such as Actinomycetes isolation agar
(AIA), Starch casein agar (SCA), Yeast peptone glucose agar
(YPG), Bennet medium (BENNET), M3 medium (M3),
Modiﬁed nutrient glucose agar medium (MNGA), ISP-
International Streptomyces Project No. 2 (ISP-2),
ISP-International Streptomyces Project No. 4 (ISP-4), ISP-
International Streptomyces Project No. 6 (ISP-6), and
ISP-International Streptomyces Project No. 7 (ISP-7). The
results were recorded after incubation at 30 C for 7–10 days.
2.3. Preliminary screening for antimicrobial activity
The antimicrobial activities of isolated actinomycetes were per-
formed by cross streak method.35 AIA plates were prepared
and inoculated with isolates by single streak in the centre of
petri plate and incubated at 30 C for 10 days. The plates were
then inoculated with the test organism by a single streak at 90
angles to the actinomycetes strain and incubated at 37 C over-
night. Then the antagonism of test organism was recorded.
The human bacterial pathogenic organisms such as Staphylo-
coccus aureus (MTCC-96), Micrococcus luteus (MTCC-106),
Enterococcus faecalis (MTCC-439), Bacillus subtilis (MTCC-
441), Staphylococcus epidermidis (MTCC-3615), Klebsiella
pneumonia (MTCC-109), Enterobacter aerogenes (MTCC-
111), Vibrio parahaemolyticus (MTCC-451), Yersinia enteroco-
litica (MTCC-840), Saccharomyces cerevisiae (MTCC-251),
Shigella flexneri (MTCC-1457), Proteus vulgaris (MTCC-
1771), Pseudomonas mendocina (MTCC-11808) and human
pathogenic candidal strains like Candida albicans (MTCC-
4748), Candida krusei (MTCC-9215), Candida tropicalis
(MTCC-4370) and Candida parapsilosis (MTCC-1965) and
human pathogenic fungal strains like Trichophyton mentagro-
phytes (MTCC-8476), Scopulariopsis sp. (MTCC-3553), Asper-
gillus niger (MTCC-10180), Botyritis cinerea (MTCC-2880),
Epidermo floccosum (MTCC-613), Aspergillus tubingenis
(MTCC-961) and Aspergillus brasiliensis (MTCC-1344) were
used in the present study.omycetes from Western Ghats of Tamil Nadu, India, Alex J Med (2016), http://
Table 1 Preliminary screening of active isolates of actinomycetes using cross streak method against different microbial pathogens.
Pathogens Active strains
FMS-20 TGH-30 TGH-31 TGH-31-1 IS-4
S. aureus (MTCC-96) +++ +++ +++ + +++
M. luteus (MTCC-106) +++ +++ +++ +++ +++
E. faecalis (MTCC-439) +++ +++ + +++ +++
B. subtilis (MTCC-449) +++ +++ +++ +++ +++
S. epidermidis (MTCC-3615) +++ +++ +++ +++ 
K. pneumonia (MTCC-109) +++ +++ +++ +++ +++
E. aerogenes (MTCC-111) +++ ++ +++  ++
V. parahaemolyticus (MTCC-451) +++ +++ ++ +++ +++
Y. enterocolitica (MTCC-840) +++ +++ +++ +++ +++
S. cerevisiae (MTCC-251) +++ +++ +++ +++ +++
S. flexneri (MTCC-1457) +++ +++ ++ +++ +
P. vulgaris (MTCC-1771) +++ +++ +++ +++ +++
P. mendocina (MTCC-11808) +++ + +++ +++ +
C. albicans (MTCC-4748) +++ +++ +++ +++ +++
C. krusei (MTCC-9215) +++ +++ ++ +++ +++
C. parapsilosis (MTCC-1965) +++ +++ +++ +++ ++
C. tropicalis (MTCC-4370) +++ +++ +++ +++ +++
T. mentagrophytes (MTCC-8476) +++ +  +++ +++
Scopulariopsis sp. (MTCC-3553) +++ +++ +++ +++ ++
A. niger (MTCC-10180) +++ +++ +++ +++ +++
B. cinerea (MTCC-2880) +++ +++ +++ + +++
E. floccosum (MTCC-613) +++ + +++ +++ +++
A. tubingenis (MTCC-1344) +++ +++ + +++ 
A. brasiliensis (MTCC-961) +++ +++ +++ +++ +++
+++: Good activity; ++: Moderate activity; +: Weak activity; : No activity.
Figure 1 Preliminary screening of active isolates of Streptomyces
rimosus (FMS-20) using cross streak method against different
bacterial pathogens.
Figure 2 Morphological analysis of Streptomyces rimosus
(FMS-20) in YPG medium.
Antimicrobial activity of some actinomycetes 32.4. Medium optimization
The active isolates were grown in different media for the pro-
duction of bioactive compounds in an orbital shaker (150 r/
min) at 30 C (M3 medium, MNGA, YPG, BENNET andPlease cite this article in press as: Ganesan P et al. Antimicrobial activity of some actin
dx.doi.org/10.1016/j.ajme.2016.03.004ISP-2). After the growth the culture broth was centrifuged
and the supernatant was used for secondary screening.
2.5. Secondary screening for antimicrobial activity
The antimicrobial activity of selected strains was tested using
ﬁltrates against all the abovementioned human microbial
pathogens using Nathans agar well diffusion method.36omycetes from Western Ghats of Tamil Nadu, India, Alex J Med (2016), http://
Figure 4 Antimicrobial activity of intracellular methanol crude
extract of Streptomyces rimosus (FMS-20) against T. mentagro-
phytes (MTCC-8476).
Table 2 Morphological characterization of the active isolates of Streptomyces rimosus (FMS-20).
Medium Characters
Aerial mycelium Substrate mycelium Soluble pigment Colony margin Growth Gram stain
ISP-2 Brown Yellow – Filaments +++ +
ISP-4 Brown White – Filaments +++ +
ISP-6 Brown Yellow Brown Filaments +++ +
ISP-7 – – – –  
YPG Brown Golden yellow – Filaments +++ +
MNGA Brownish yellow Yellow – Filaments +++ +
M3 Slimy yellow Yellow – Filaments +++ +
AIA Brown Brown – Filaments +++ +
SCA Brown Yellow – Filaments +++ +
BENNET Brown Yellow – Filaments +++ +
+++: Good growth; : no soluble pigment, Gram stain; +: positive; : negative.
Table 3 Biochemical characterization of the active isolates of
Streptomyces rimosus (FMS-20).
Test +ve/ve
Indole 
Voges-Proskauer test 
Citrate test 
Lysine test 
Ornithine test 
Arginine test 
Nitrate test +
Malonate test 
Urease test 
Phenylalanine-deamination test 
H2S production test 
ONPG test 
Glucose +
Mannitol +
Xylose +
Inositol +
Sorbitol 
Rhamnose 
Sucrose 
Lactose 
Arabinose 
Adonitol 
Raﬃnose 
Salicin 
+: Positive; : negative.
Figure 3 Antimicrobial activity of extracellular ethylacetate
crude extract of Streptomyces rimosus (FMS-20) against B. subtilis
(MTCC-441).
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dx.doi.org/10.1016/j.ajme.2016.03.0042.6. Day optimization
For day optimization, the active strain was cultured in the
selected (well grown) production media ISP-2 for up to 3–
16 days following established method.21,37
2.7. Biochemical characterization
The active isolates were selected for biochemical studies. Bio-
chemical characterization was done by using biochemical kit
(KB014 HiAcinetobacter Identiﬁcation Kit) according to the
manufacturer’s protocol. For biochemical tests urea hydroly-omycetes from Western Ghats of Tamil Nadu, India, Alex J Med (2016), http://
Table 4 Antimicrobial activities (in mm) of extracellular ethyl acetate crude extract of Streptomyces rimosus (FMS-20).
Pathogens Streptomyces rimosus (FMS-20)
Control 1.5 mg/disc 2.50 mg/disc 5.0 mg/disc
S. aureus (MTCC-96) 11 16 18 21
M. luteus (MTCC-106) 14 13 15 17
E. faecalis (MTCC-439) 10 11 13 17
B. subtilis (MTCC-449) 19 18 22 25
S. epidermidis (MTCC-3615) 0 10 12 14
K. pneumonia (MTCC-109) 11 14 16 18
E. aerogenes (MTCC-111) 10 12 14 16
V. parahaemolyticus (MTCC-451) 18 16 18 21
Y. enterocolitica (MTCC-840) 16 19 20 24
S. cerevisiae (MTCC-251) 18 11 12 14
S. flexneri (MTCC-1457) 10 11 12 13
P. vulgaris (MTCC-1771) 13 14 16 18
P. mendocina (MTCC-11808) 16 11 12 15
C. albicans (MTCC-4748) 13 15 17 19
C. krusei (MTCC-9215) 0 14 18 21
C. parapsilosis (MTCC-1965) 12 15 16 18
C. tropicalis (MTCC-4370) 14 10 17 20
T. mentagrophytes (MTCC-8476) 13 0 0 0
Scopulariopsis sp. (MTCC-3553) 20 0 0 0
A. niger (MTCC-10180) 14 0 0 0
B. cinerea (MTCC-2880) 23 0 0 0
E. floccosum (MTCC-613) 20 0 0 0
A. tubingenis (MTCC-1344) 25 0 0 0
A. brasiliensis (MTCC-961) 15 0 0 0
Table 5 Antimicrobial activities (in mm) of intracellular methanol crude extract of Streptomyces rimosus (FMS-20).
Pathogens Streptomyces rimosus (FMS-20)
Control 1.5 mg/disc 2.50 mg/disc 5.0 mg/disc
S. aureus (MTCC-96) 12 0 0 0
M. luteus (MTCC-106) 14 0 0 0
E. faecalis (MTCC-439) 10 0 0 0
B. subtilis (MTCC-449) 20 0 0 0
S. epidermidis (MTCC-3615) 0 0 0 0
K. pneumonia (MTCC-109) 11 0 0 0
E. aerogenes (MTCC-111) 10 0 0 0
V. parahaemolyticus (MTCC-451) 20 0 0 0
Y. enterocolitica (MTCC-840) 16 0 0 0
S. cerevisiae (MTCC-251) 17 0 0 0
S. flexneri (MTCC-1457) 12 0 0 0
P. vulgaris (MTCC-1771) 18 0 0 0
P. mendocina (MTCC-11808) 15 0 0 0
C. albicans (MTCC-4748) 13 0 0 0
C. krusei (MTCC-9215) 0 0 0 0
C. parapsilosis (MTCC-1965) 12 0 0 0
C. tropicalis (MTCC-4370) 14 0 0 0
T. mentagrophytes (MTCC-8476) 12 16 17 19
Scopulariopsis sp. (MTCC-3553) 24 10 13 15
A. niger (MTCC-10180) 0 14 16 20
B. cinerea (MTCC-2880) 24 10 11 13
E. floccosum (MTCC-613) 24 10 13 14
A. tubingenis (MTCC-1344) 25 12 14 18
A. brasiliensis (MTCC-961) 18 17 19 22
Antimicrobial activity of some actinomycetes 5sis, acid production indole, Voges-Proskauer, citrate, lysine,
ornithine, arginine, nitrate, malonate, urease, Phenylalanine-
deamination, H2S production, ONPG, glucose, mannitol,
xylose, inositol, sorbitol, rhamnose, sucrose, lactose, arabi-
nose, adonitol and rafﬁnose were carried out.Please cite this article in press as: Ganesan P et al. Antimicrobial activity of some actin
dx.doi.org/10.1016/j.ajme.2016.03.0042.8. Crude extract preparation
2.8.1. Extra cellular
The total culture ﬁltrate (20 l) of selected strain (FMS-20) was
used for solvent extractions using ethyl acetate. The ratio 1:1omycetes from Western Ghats of Tamil Nadu, India, Alex J Med (2016), http://
Figure 5 Phylogenetic tree indicating the taxonomic position of Streptomyces rimosus (FMS-20).
Figure 6 Restriction sites on the 16S rRNA sequence of Streptomyces rimosus (FMS-20).
6 P. Ganesan et al.(v/v) of the solvent and ﬁltrate was shaken and mixed well. The
upper layer was collected using separating funnel and solvents
were evaporated using rotary evaporator.Please cite this article in press as: Ganesan P et al. Antimicrobial activity of some actin
dx.doi.org/10.1016/j.ajme.2016.03.0042.8.2. Intra cellular
The mycelia of the active actinomycetes were soaked in metha-
nol and kept in shaker for about two days at 180 r/min. Finallyomycetes from Western Ghats of Tamil Nadu, India, Alex J Med (2016), http://
Figure 7 Secondary structure of 16S rRNA sequence of Streptomyces rimosus (FMS-20).
Antimicrobial activity of some actinomycetes 7it was ﬁltered with blotting paper and crude extract was sepa-
rated using rotary evaporator.
2.9. Antimicrobial activity of crude extracts
Antimicrobial activity of crude extract was carried out using
disc diffusion method.38 Petri plates were prepared with
20 ml of sterile Muller Hinton agar (MHA, Himedia) for bac-
teria and potato dextrose agar (PDA Himedia) for fungal
pathogens. The selected human pathogens were swabbed on
top of the solidiﬁed media. The crude extracts were tested at
1.25 mg, 2.50 mg and 5.0 mg/disc concentrations. Control
was maintained separately; streptomycin for bacteria and keto-
conazole for fungi (25 lg/disc) were used as positive controls.
The loaded discs were placed on the surface of the medium
and left for 30 min at room temperature for diffusion. The
plates were incubated overnight at 37 C and zones of inhibi-
tion were recorded.18
2.10. Genomic DNA isolation
The genomic DNA of active strain (FMS-20) was isolated
using the HipurA Streptomyces DNA puriﬁcation kit-MB
527–50 pr (Himedia), according to the manufacturer’s instruc-
tions. Brieﬂy, the pure cultures were pelleted by centrifuging
for 2 min at 12,000 r/min to obtain 10–15 mg (wet weight).
The cells were resuspended thoroughly in 300 ll of lysis solu-
tion. 20 ll of RNase A solution was added, mixed and incu-
bated for 2 min at room temperature. Then 20 ll of
proteinase K solution (20 mg/ml) was added. The samples
were mixed and resuspended. The cells were transferred to
the Hibead Tube and incubated for 30 min at 55 C. The mix-
ture was vortexed for 5–7 min and incubated for 10 min at
95 C followed by pulse vortexing. Supernatant was collected
by centrifuging the tube at 10,000 r/min for 1 min at room tem-
perature. About 200 ll of lysis solution was added, mixed thor-
oughly by vortexing and incubated at 55 C for 10 min. To the
lysate 200 ll of ethanol (96–100%) was added and mixed thor-Please cite this article in press as: Ganesan P et al. Antimicrobial activity of some actin
dx.doi.org/10.1016/j.ajme.2016.03.004oughly by vortexing for 15 s. The lysate was transferred to new
spin column and centrifuged at 10,000 r/min for 1 min and the
supernatant was discarded. The lysate was then washed in
500 ll of prewash solution which was added to the spin col-
umn and centrifuged at 10,000 r/min for 1 min and the super-
natant was discarded. The lysate was then washed in 500 ll of
wash solution and centrifuged at 1000 r/min for 3 min. Two
hundred microlitre of the elution buffer was pipetted out and
added directly into the column without spilling, and incubated
for one min at room temperature. Finally the DNA was eluted
by centrifuging the column at 10,000 r/min for one min.
2.11. Analysis of 16S rRNA
The primers 27F (50AGAGTTTGATCMTGGCTCAG30) and
1492R (50TACGGYTACCTTGTTACGACTT 30) were used
to amplify 16S ribosomal sequence from genomic DNA in
thermal cycler (ep gradient Eppendorf). The cyclic conditions
are as follows: initial denaturation at 94 C for 3 min, 35 cycles
of denaturation 94 C for 1 min, annealing 54 C for 1 min,
extension 72 C for 2 min, and ﬁnal extension 72 C for
7 min and ﬁnally hold at 4 C. The PCR products were con-
ﬁrmed by 1% agarose gel electrophoresis.18,20,39
2.12. DNA sequence determination
Automated sequencing was carried out according to the
dideoxy chain–termination method using applied Biosystems
automated sequencer by Synergy Scientiﬁc Services.
2.13. Phylogenetic studies and species identification
The sequences were compared for similarity with the reference
species of bacteria contained in genomic database, using the
NCBI BLAST tool (http://www.ncbi.nlm.nih.gov/BLAST).
The DNA sequences were aligned and phylogenetic tree was
constructed based on bootstrap test of phylogeny with
neighbour-joining method using MEGA4 software. The 16Somycetes from Western Ghats of Tamil Nadu, India, Alex J Med (2016), http://
8 P. Ganesan et al.rRNA sequence was submitted to the GenBank, NCBI,
USA.40
2.14. 16S rRNA secondary structure and restriction sites
analysis
The 16S rRNA secondary structure of the DNA sequence was
predicted using RNA structure version 5.7 software (Mathews
Lab, University of Rochester Medical Centre) and restriction
site was identiﬁed using NEB cutter online tool version 2.0
(nc2.neb.com/nebcutter2/).41,42
3. Results
3.1. Isolation and selection of actinomycetes
The isolated strains were identiﬁed morphologically based on
the colony, sporulation and pigment in the dilution plate. A
total of 106 actinomycetes strains was selected and inoculated
into the AIA medium for puriﬁcation. The pure strains were
named as FMS-20 to FMS-35, TGH-20 to TGH-35, NDM-
20 to NDM-59, IS-1 to IS-8, and KS-1 to KS-26. These iso-
lates were maintained in ISP2 medium.
3.2. Preliminary and secondary screening
All the 106 isolates were screened against human bacterial, fun-
gal, and candida pathogens. Only 44 (41.50%) isolates showed
good antimicrobial activity against pathogens. The percentage
of activity to each pathogen is listed below: MTCC 96-19.8%,
MTCC 106-20.7%, MTCC 439-17.9%, MTCC 441-10.3%,
MTCC 3615-8.4%, MTCC MTCC 109-4.7%, MTCC 111-
6.6%, MTCC 451-23.4%, MTCC 840-12.2%, MTCC 251-
10.3%, MTCC 1457-22.6%, MTCC 1771-25.4%, MTCC
11808-10.3% MTCC 9215-15%, MTCC 4370-14.1%,
MTCC 1965-14.1%, MTCC 4748-14.1%, MTCC 8476-
14.1%, MTCC 3553-14.1%, MTCC 2030-14.1%, MTCC
2880-14.1%, MTCC 613-14.1%, MTCC 1344-14.1%, and
MTCC 961-14.1%. Among them, 5 strains (TGH-30, TGH-
31, TGH-31-1, FMS-20, and IS-4) showed very good activity
against different human pathogens. These cultures were chosen
for secondary screening (Table 1 and Fig. 1). The results
revealed that FMS-20 alone showed highest antimicrobial
activity against all the pathogens.
3.3. Medium and day optimization
Among the ﬁve active strains (FMS-20, TGH-30, TGH-31,
TGH-31-1, and IS-4), only FMS-20 which grew in ISP-2 med-
ium inhibited highly all the human pathogens. The day opti-
mization results showed that FMS-20 recorded highest zone
of inhibition on 16th day.
3.4. Morphological characterization
The colony morphology of active strain (FMS-20) was noted
with respect to colour, aerial and substrate mycelium, soluble
pigment, colony margin, Gram staining, and growth of colony.
The results are given in Table 2 and Fig. 2.Please cite this article in press as: Ganesan P et al. Antimicrobial activity of some actin
dx.doi.org/10.1016/j.ajme.2016.03.0043.5. Biochemical characterization
The active strain (FMS-20) was selected for biochemical stud-
ies. The strain showed positive results for nitrate, glucose,
mannitol, xylose, and inositol. The results are summarized in
Table 3.
3.6. Antibacterial activity of crude extracts using disc diffusion
method
Extra cellular ethyl acetate crude extract of active strain FMS-
20 showed good activity against all the tested human patho-
genic bacteria and candida. They did not show any activity
against fungal pathogens (Table 4 and Fig. 3). Intracellular
methanol extract of FMS-20 also showed good activity against
human fungal pathogens and it did not show any activity
against bacterial and candidal pathogens (Table 5 and Fig. 4).
3.7. PCR amplification of FMS-20 genomic DNA
The genomic DNA was isolated using the HipurA Strepto-
myces DNA puriﬁcation kit-MB 527-50 pr (Himedia) and
the isolated genomic DNA was conﬁrmed in 1% agarose gel
stained with ethidium bromide. DNA was observed under
UV Transilluminator and it showed good yield of DNA. The
PCR product was analysed in 1% agarose gel electrophoresis
and the size (1500 bp) was conﬁrmed, sequenced and submit-
ted in the GenBank (KT827106).
3.8. Molecular identification
The isolated active strain FMS-20 (KT827106) showed 98%
homology to Streptomyces rimosus strain NBRC 12907 16S
ribosomal RNA gene partial sequence (NR_112332). The
DNA sequence was aligned and phylogenetic tree was con-
structed by using MEGA4 software and the results revealed
that FMS-20 indicated 98% similarity to S. rimosus (Fig. 5).
3.9. 16S rRNA secondary structure and restriction sites analysis
The restriction analysis of 16S rRNA sequence of FMS-20
indicated the presence of GCAT content to 59% & 41%
respectively (Fig. 6). The energy of the predicted structure
was 303.9 kkal/mol (Fig. 7).
4. Discussion
In the present work totally 106 actinomycete strains were iso-
lated from ﬁve different soil samples. These strains were cross
streaked against microbial pathogens. The preliminary and
secondary screening results clearly showed that FMS-20 alone
possessed very high antimicrobial activity against all the tested
human pathogens. Oskay et al.35 screened 50 actinomycetes
isolated from Cyprus soil against several human pathogens.
It was found that 34% of strains produced antibiotics. Valan
Arasu et al.43 isolated a strain of Streptomyces sp. from Wes-
tern Ghats soil sample and reported that it was very effective
against S. aureus, S. epidermidis, Xanthomonas sp. and C. albi-
cans at 0.25 mg/ml concentration.omycetes from Western Ghats of Tamil Nadu, India, Alex J Med (2016), http://
Antimicrobial activity of some actinomycetes 9Further, in the present study, the intracellular methanol
extract of FMS-20 showed maximum zone of inhibition of
22 mm against A. brasiliensis and lowest zone of inhibition
of 14 mm against E. floccosum at 5 mg/disc. The extracellular
ethylacetate extract of FMS-20 showed maximum zone of inhi-
bition of 25 mm against B. subtilis and lowest zone of inhibi-
tion of 13 mm against S. flexneri at 5 mg/disc. These results
were comparable with the previous report of Vijayakumar
et al.44 who reported that ethyl acetate extract of Streptomyces
sp. was more active by producing highest zone of inhibition of
23 mm against P. vulgaris and lowest zone of inhibition of
15 mm against S. aureus. In another study Balachandran
et al.45 reported extra cellular ethyl acetate extract of Methy-
lobacterium sp. with highest zone of inhibition of 13 mm
against K. pneumonia and lowest zone of inhibition of 9 mm
against B. subtilis. Saravanakumar et al.18 reported that intra-
cellular methanol extract of Actinobacterium showed maxi-
mum zone of inhibition of 21 mm against P. vulgaris and
lowest zone inhibition of 15 mm against B. subtilis.
In several reports, ethyl acetate was mostly used as an
extraction solvent to isolate the crude extracts from actino-
mycetes.46,47 Earlier several studies reported that most of the
antimicrobial secondary metabolites were from extracellular
actinomycetes.48–50 The active strain FMS-20 is taxonomically
very close to S. rimosus (98% similarity). This was conﬁrmed
by blast and phylogenetic analysis. S. rimosus was Gram pos-
itive and ﬁlamentous. It showed brown colour in appearance.
This strain is notably the most identiﬁed producer of oxytetra-
cycline and other tetracycline class of antibiotics such as
Polypeptides.51–54 Earlier, some researchers studied the crude
extracts of actinomycetes on animal model. In a study, Sugan-
thi et al.55 isolated Streptomyces sp. from marine environment
and checked for toxicity changes in Wistar albino rats. The
extract showed no haematological, biochemical and
histopathological changes in long time treatment. Similarly,
Taweel et al.56 tested the crude extract of actinomycetes viz.,
Streptomyces fradiae, Streptomyces clavus and Streptomyces
roseoflavus against Ehrlich Ascites Carcinoma (EAC) on ani-
mal model using swiss albino mice. The result showed 67%,
64.2% and 75% of anticancer activity against S. fradiae, S.
clavus and S. roseoflavus, respectively.
5. Conclusion
In conclusion, the extra cellular ethyl acetate crude extract of
S. rimosus showed good activity against all the tested human
pathogenic bacteria and candida. Similarly, intracellular
methanol extract of S. rimosus also showed good activity
against human fungal pathogens. The present results suggest
that the isolated actinomycete S. rimosus (FMS-20) could be
used as antibacterial and antifungal agent against the tested
microbial pathogens.
Recommendation
The active ethyl acetate crude extract of S. rimosus may possi-
bly be taken up further to identify the active principle and the
efﬁcacy of such active compound may also be tested with ani-
mal model.Please cite this article in press as: Ganesan P et al. Antimicrobial activity of some actin
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